Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term therapy. Found 488 abstracts

no pagination
Murphy CT, Galloway TJ, Handorf EA, Egleston BL, Wang LS, Mehra R, Flieder DB, Ridge JA. Survival Impact of Increasing Time to Treatment Initiation for Patients With Head and Neck Cancer in the United States. J Clin Oncol. 2016 Jan 10;34(2):169-78.   PMCID: PMC4858932
Su F, Myers VD, Knezevic T, Wang J, Gao E, Madesh M, Tahrir FG, Gupta MK, Gordon J, Rabinowitz J, Ramsey FV, Tilley DG, Khalili K, Cheung JY, Feldman AM. Bcl-2-associated athanogene 3 protects the heart from ischemia/reperfusion injury. JCI insight. 2016 Nov 17;1(19):e90931.   PMCID: PMC5111510
Winn JS, Baker MG, Fanous IS, Slack-Davis JK, Atkins KA, Dillon PM. Lobular Breast Cancer and Abdominal Metastases: A Retrospective Review and Impact on Survival. Oncology. 2016 Jan;91(3):135-42.
Wong YN, Schluchter MD, Albrecht TL, Benson AB, Buzaglo J, Collins M, Flamm AL, Fleisher L, Katz M, Kinzy TG, Liu TM, Manne S, Margevicius S, Miller DM, Miller SM, Poole D, Raivitch S, Roach N, Ross E, Meropol NJ. Financial Concerns About Participation in Clinical Trials Among Patients With Cancer. J Clin Oncol. 2016 Feb 10;34(5):479-87.   PMCID: PMC4872013
Zibelman M, Plimack ER. Systemic therapy for bladder cancer finally comes into a new age. Future Oncol. 2016 Oct;12(19):2227-42.   PMCID: PMC5066115
Ajani JA, D'Amico TA, Almhanna K, Bentrem DJ, Besh S, Chao J, Das P, Denlinger C, Fanta P, Fuchs CS, Gerdes H, Glasgow RE, Hayman JA, Hochwald S, Hofstetter WL, Ilson DH, Jaroszewski D, Jasperson K, Keswani RN, Kleinberg LR, Korn WM, Leong S, Lockhart AC, Mulcahy MF, Orringer MB, Posey JA, Poultsides GA, Sasson AR, Scott WJ, Strong VE, Varghese TK, Washington MK, Willett CG, Wright CD, Zelman D, McMillian N, Sundar H, National comprehensive cancer n. Esophageal and esophagogastric junction cancers, version 1.2015. J Natl Compr Canc Netw. 2015 Feb;13(2):194-227.
Anderson KC, Alsina M, Atanackovic D, Biermann JS, Chandler JC, Costello C, Djulbegovic B, Fung HC, Gasparetto C, Godby K, Hofmeister C, Holmberg L, Holstein S, Huff CA, Kassim A, Krishnan AY, Kumar SK, Liedtke M, Lunning M, Raje N, Singhal S, Smith C, Somlo G, Stockerl-Goldstein K, Treon SP, Weber D, Yahalom J, Shead DA, Kumar R. Multiple myeloma, version 2.2016: Clinical practice guidelines in oncology. JNCCN Journal of the National Comprehensive Cancer Network. 2015 Nov;13(11):1398-435.   PMCID: PMC4891187
Ansell SM, Lesokhin AM, Borrello I, Halwani A, Scott EC, Gutierrez M, Schuster SJ, Millenson MM, Cattry D, Freeman GJ, Rodig SJ, Chapuy B, Ligon AH, Zhu L, Grosso JF, Kim SY, Timmerman JM, Shipp MA, Armand P. PD-1 blockade with nivolumab in relapsed or refractory Hodgkin's lymphoma. The New England journal of medicine. 2015 Jan 22;372(4):311-9.   PMCID: 4348009
Balamucki CJ, DeJesus R, Galloway TJ, Mancuso AA, Amdur RJ, Morris CG, Kirwan JM, Mendenhall WM. Impact of radiographic findings on for prognosis skin cancer with perineural invasion. Am J Clin Oncol. 2015 Jun;38(3):248-51.
Barrington SF, Mikhaeel NG, Kostakoglu L, Meignan M, Hutchings M, Mueller S, Schwartz LH, Zucca E, Fisher RI, Trotman J, Hoekstra OS, Hicks RJ, O'Doherty MJ, Hustinx R, Biggi A, Cavalli F, Lister TA, Cheson BD. Reply to B. Bennani-Baiti et al, H.J.A. Adams et al, E. Laffon et al, and E.A. Hawkes et al [Letter]. J Clin Oncol. 2015 Apr;33(10):1221-3.
Barrington SF, Mikhaeel NG, Kostakoglu L, Meignan M, Hutchings M, Mueller S, Schwartz LH, Zucca E, Fisher RI, Trotman J, Hoekstra OS, Hicks RJ, O'Doherty MJ, Hustinx R, Biggi A, Cavalli F, Lister TA, Cheson BD. Reply to B. Bennani-Baiti et al, H.J.A. Adams et al, E. Laffon et al, and E.A. Hawkes et al. J Clin Oncol. 2015 Apr;33(10):1221-3.
Bennett C, Moayyedi P, Corley DA, DeCaestecker J, Falck-Ytter Y, Falk G, Vakil N, Sanders S, Vieth M, Inadomi J, Aldulaimi D, Ho KY, Odze R, Meltzer SJ, Quigley E, Gittens S, Watson P, Zaninotto G, Iyer PG, Alexandre L, Ang Y, Callaghan J, Harrison R, Singh R, Bhandari P, Bisschops R, Geramizadeh B, Kaye P, Krishnadath S, Fennerty MB, Manner H, Nason KS, Pech O, Konda V, Ragunath K, Rahman I, Romero Y, Sampliner R, Siersema PD, Tack J, Tham TC, Trudgill N, Weinberg DS, Wang J, Wang K, Wong JY, Attwood S, Malfertheiner P, MacDonald D, Barr H, Ferguson MK, Jankowski J. BOB CAT: a Large-Scale Review and Delphi Consensus for Management of Barrett's Esophagus With No Dysplasia, Indefinite for, or Low-Grade Dysplasia. Am J Gastroenterol. 2015 Apr 14;110(5):662-82.   PMCID: 4436697
Berger AM, Mooney K, Alvarez-Perez A, Breitbart WS, Carpenter KM, Cella D, Cleeland C, Dotan E, Eisenberger MA, Escalante CP, Jacobsen PB, Jankowski C, LeBlanc T, Ligibel JA, Loggers ET, Mandrell B, Murphy BA, Palesh O, Pirl WF, Plaxe SC, Riba MB, Rugo HS, Salvador C, Wagner LI, Wagner-Johnston ND, Zachariah FJ, Bergman MA, Smith C, National comprehensive cancer n. Cancer-Related Fatigue, Version 2.2015. J Natl Compr Canc Netw. 2015 Aug;13(8):1012-39.   PMCID: PMC5499710
Bhatia A, Burtness B. Human Papillomavirus-Associated Oropharyngeal Cancer: Defining Risk Groups and Clinical Trials. J Clin Oncol. 2015 Oct 10;33(29):3243-50.   PMCID: PMC5814107
Camacho-Rivera M, Ragin C, Roach V, Kalwar T, Taioli E. Breast cancer clinical characteristics and outcomes in Trinidad and Tobago. Journal of immigrant and minority health. 2015 Jun;17(3):765-72.
Cornejo KM, Deng A, Wu H, Cosar EF, Khan A, St Cyr M, Tomaszewicz K, Dresser K, O'Donnell P, Hutchinson L. The utility of MYC and FLT4 in the diagnosis and treatment of postradiation atypical vascular lesion and angiosarcoma of the breast. Hum Pathol. 2015 Jun;46(6):868-75.
Deng XB, Xiao L, Wu Y, Jin F, Mossman B, Testa JR, Xiao GH. Inhibition of mesothelioma cancer stem-like cells with adenovirus-mediated NK4 gene therapy. International journal of cancer. 2015 Jul 15;137(2):481-90.   PMCID: PMC4428975
El-Deiry WS, Vijayvergia N, Xiu J, Scicchitano A, Lim B, Yee NS, Harvey HA, Gatalica Z, Reddy S. Molecular profiling of 6,892 colorectal cancer samples suggests different possible treatment options specific to metastatic sites. Cancer Biol Ther. 2015 Jan;16(12):1726-37.   PMCID: PMC4847814
Ettinger DS, Wood DE, Akerley W, Bazhenova LA, Borghaei H, Camidge DR, Cheney RT, Chirieac LR, D'Amico TA, Demmy TL, Dilling TJ, Dobelbower MC, Govindan R, Grannis FW, Horn L, Jahan TM, Komaki R, Krug LM, Lackner RP, Lanuti M, Lilenbaum R, Lin J, Loo BW, Martins R, Otterson GA, Patel JD, Pisters KM, Reckamp K, Riely GJ, Rohren E, Schild SE, Shapiro TA, Swanson SJ, Tauer K, Yang SC, Gregory K, Hughes M. Non-small cell lung cancer, version 6.2015. J Natl Compr Canc Netw. 2015 May;13(5):515-24.
Feitelson MA, Arzumanyan A, Kulathinal RJ, Blain SW, Holcombe RF, Mahajna J, Marino M, Martinez-Chantar ML, Nawroth R, Sanchez-Garcia I, Sharma D, Saxena NK, Singh N, Vlachostergios PJ, Guo S, Honoki K, Fujii H, Georgakilas AG, Bilsland A, Amedei A, Niccolai E, Amin A, Ashraf SS, Boosani CS, Guha G, Ciriolo MR, Aquilano K, Chen S, Mohammed SI, Azmi AS, Bhakta D, Halicka D, Keith WN, Nowsheen S. Sustained proliferation in cancer: Mechanisms and novel therapeutic targets. Semin Cancer Biol. 2015 Dec;35 Suppl:S25-54.   PMCID: PMC4898971
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term therapy

therapy pathology Female Middle Aged diagnosis Male genetics Adult methods Aged metabolism Risk Factors Head and Neck Neoplasms Antineoplastic Agents X-Ray Computed Tomography Neoplasms Lung Neoplasms Age Factors etiology analysis Breast Neoplasms therapeutic use drug effects Tumor Biomarkers Squamous Cell Carcinoma Combined Modality Therapy Fluorodeoxyglucose F18 Clinical Trials as Topic Immunohistochemistry Positron-Emission Tomography adverse effects Disease-Free Survival Disease Management radionuclide imaging Esophageal Neoplasms Neoplasm Staging Prognosis Survival Rate Lymphoma Progesterone Receptors secondary Neoplasm Metastasis Estrogen Receptors complications Radiopharmaceuticals Neoplastic Stem Cells mortality Immunotherapy STAT Transcription Factors organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those virology Epithelial-Mesenchymal Transition Proto-Oncogene Proteins c-met Genetic Testing Colorectal Neoplasms Breast Xenograft Model Antitumor Assays Vascular Diseases neoadjuvant chemotherapy Basal Cell Carcinoma High-Throughput Nucleotide Sequencing Kaplan-Meier Estimate Apoptosis Stem Cell Transplantation immunotherapy Odds Ratio Programmed Cell Death 1 Ligand 2 Protein Ductal Carcinoma-Breast Segmental Mastectomy checkpoint blockade Standard of Care Janus Kinases Lobular Carcinoma Mutation Signal Transducing Adaptor Proteins Apoptosis Regulatory Proteins Barrett Esophagus DNA Methylation Conflict (Psychology) Skin Neoplasms Surveys and Questionnaires Fatigue Esophagus Gene Amplification AstraZeneca and Merck directed clinical trial support from Bristol-Myers Squibb Western Blotting Reed-Sternberg Cells Gene Expression Profiling Genetic Therapy 80 and over Aged Reperfusion Injury diagnostic use Self Efficacy Ctla-4 radiography Myc Local Neoplasm Recurrence Cox2 Carcinoma Kras Attitudes Health Knowledge-Practice Non-Small-Cell Lung Carcinoma Type II DNA Topoisomerases Magnetic Resonance Imaging Delayed Diagnosis Proportional Hazards Models c-MET Pd-1 bladder cancer beta Catenin Genetic Vectors Registries colorectal cancer Nude Mice Follow-Up Studies Trinidad and Tobago oxaliplatin HGF Apc Hemangiosarcoma cancer stem-like cells Cellular Spheroids Autophagy Decision Support Techniques Patient Education as Topic biosynthesis Cultured Cells Cell Hypoxia Radiotherapy Dosage ErbB-2 Receptor Phosphorylation disclosed No writing assistance was utilized in the production of this Atypical vascular lesion Her2 urothelial carcinoma The authors have no other relevant affiliations or financial involvement with any Urinary Bladder Neoplasms Esophagoscopy precision medicine Cell Survival Cell Cycle Proteins Retrospective Studies irinotecan Papillomavirus Infections institutionally directed clinical trial support from Horizon Pharma ER Plimack Peripheral Nerves Nk4 molecular profiling Sulfones
Last updated on Saturday, August 15, 2020